The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
 
Jason Zhu
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - UroToday
 
Sarabjot Pabla
Employment - OmniSeq
 
Matthew Labriola
No Relationships to Disclose
 
Rajan T. Gupta
No Relationships to Disclose
 
Shannon McCall
No Relationships to Disclose
 
Daniel J. George
Honoraria - Bayer; Exelixis; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Exelixis; Genentech; Innocrin Pharma; Janssen; Merck Sharp & Dohme; Myovant Sciences; Pfizer; Sanofi
Speakers' Bureau - Bayer; Exelixis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Merck; Pfizer; Sanofi
 
Devin Dressman
Employment - OmniSeq
 
Sean T. Glenn
Employment - OmniSeq
 
Mary Nesline
Employment - OmniSeq
 
Saby George
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; Exelixis; Genentech/Roche; Janssen Oncology; Novartis; Pfizer; Sanofi
Research Funding - Acceleron Pharma (Inst); Agensys (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Carl Morrison
Employment - OmniSeq
Leadership - OmniSeq
Stock and Other Ownership Interests - OmniSeq
Consulting or Advisory Role - NanoString Technologies
Patents, Royalties, Other Intellectual Property - OmniSeq (Inst)
 
Tian Zhang
Leadership - Capio BioSciences (I)
Stock and Other Ownership Interests - Capio Biosciences (I)
Honoraria - Exelixis; Genentech/Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Exelixis; Foundation Medicine; Genentech/Roche; Janssen; Pfizer; Pharmacyclics; Sanofi
Speakers' Bureau - Exelixis; Genentech/Roche; Genomic Health; Genzyme
Research Funding - Acerta Pharma (Inst); Janssen (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); OmniSeq (Inst); Personal Genome Diagnostics (Inst); Pfizer (Inst); Regeneron (Inst); Stem CentRx (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture by c-MET technology (Inst); Prochelators as Targeted Prodrugs for Prostate Cancer (Inst)
Travel, Accommodations, Expenses - Acerta Pharma